These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9589382)

  • 1. Noncompetitive inhibition of nicotinic acetylcholine receptors by endogenous molecules.
    Arias HR
    J Neurosci Res; 1998 May; 52(4):369-79. PubMed ID: 9589382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding sites for exogenous and endogenous non-competitive inhibitors of the nicotinic acetylcholine receptor.
    Arias HR
    Biochim Biophys Acta; 1998 Aug; 1376(2):173-220. PubMed ID: 9748559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topology of ligand binding sites on the nicotinic acetylcholine receptor.
    Arias HR
    Brain Res Brain Res Rev; 1997 Oct; 25(2):133-91. PubMed ID: 9403137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Doxylstearate-induced displacement of phencyclidine from its low-affinity binding sites on the nicotinic acetylcholine receptor.
    Arias HR
    Arch Biochem Biophys; 1999 Nov; 371(1):89-97. PubMed ID: 10525293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agonist self-inhibitory binding site of the nicotinic acetylcholine receptor.
    Arias HR
    J Neurosci Res; 1996 Apr; 44(2):97-105. PubMed ID: 8723217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Luminal and non-luminal non-competitive inhibitor binding sites on the nicotinic acetylcholine receptor.
    Arias HR
    Mol Membr Biol; 1996; 13(1):1-17. PubMed ID: 9147657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quinacrine and ethidium bromide bind the same locus on the nicotinic acetylcholine receptor from Torpedo californica.
    Lurtz MM; Hareland ML; Pedersen SE
    Biochemistry; 1997 Feb; 36(8):2068-75. PubMed ID: 9047305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temperature and ionic strength dependence of quinacrine binding and quinacrine displacement elicited by high concentrations of agonists on the nicotinic acetylcholine receptor.
    Arias HR
    Arch Biochem Biophys; 1996 Sep; 333(1):1-11. PubMed ID: 8806747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization of agonist and competitive antagonist binding sites on nicotinic acetylcholine receptors.
    Arias HR
    Neurochem Int; 2000 Jun; 36(7):595-645. PubMed ID: 10771117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of local anesthetics on both cholinergic and serotonergic ionotropic receptors.
    Arias HR
    Neurosci Biobehav Rev; 1999; 23(6):817-43. PubMed ID: 10541058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The high-affinity quinacrine binding site is located at a non-annular lipid domain of the nicotinic acetylcholine receptor.
    Arias HR
    Biochim Biophys Acta; 1997 Jul; 1347(1):9-22. PubMed ID: 9233683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of lipids and ligands with nicotinic acetylcholine receptor vesicles assessed by electron paramagnetic resonance spectroscopy.
    Arias HR
    Methods Mol Biol; 2010; 606():291-318. PubMed ID: 20013404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive and negative modulation of nicotinic receptors.
    Arias HR
    Adv Protein Chem Struct Biol; 2010; 80():153-203. PubMed ID: 21109220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The steroid promegestone is a noncompetitive antagonist of the Torpedo nicotinic acetylcholine receptor that interacts with the lipid-protein interface.
    Blanton MP; Xie Y; Dangott LJ; Cohen JB
    Mol Pharmacol; 1999 Feb; 55(2):269-78. PubMed ID: 9927618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the dizocilpine binding site on the nicotinic acetylcholine receptor.
    Arias HR; McCardy EA; Blanton MP
    Mol Pharmacol; 2001 May; 59(5):1051-60. PubMed ID: 11306687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of interaction of 3,4,5-trimethoxybenzoic acid 8-(diethylamino)octyl ester with Torpedo californica nicotinic acetylcholine receptor and 5-hydroxytryptamine3 receptor.
    Sun H; McCardy EA; Machu TK; Blanton MP
    J Pharmacol Exp Ther; 1999 Jul; 290(1):129-35. PubMed ID: 10381768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noncompetitive antagonist binding sites in the torpedo nicotinic acetylcholine receptor ion channel. Structure-activity relationship studies using adamantane derivatives.
    Arias HR; Trudell JR; Bayer EZ; Hester B; McCardy EA; Blanton MP
    Biochemistry; 2003 Jun; 42(24):7358-70. PubMed ID: 12809491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms and binding site locations for noncompetitive antagonists of nicotinic acetylcholine receptors.
    Arias HR; Bhumireddy P; Bouzat C
    Int J Biochem Cell Biol; 2006; 38(8):1254-76. PubMed ID: 16520081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockage of mouse muscle nicotinic receptors by serotonergic compounds.
    García-Colunga J; Miledi R
    Exp Physiol; 1999 Sep; 84(5):847-64. PubMed ID: 10502654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agonist-induced displacement of quinacrine from its binding site on the nicotinic acetylcholine receptor: plausible agonist membrane partitioning mechanism.
    Arias HR
    Mol Membr Biol; 1995; 12(4):339-47. PubMed ID: 8747279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.